Literature DB >> 21686139

The prevalence and risk factors of decreased bone mineral density in firstly diagnosed ulcerative colitis patients in the eastern region of Turkey.

Levent Ediz, Ahmet Cumhur Dülger, Murat Toprak, Mehmet Fethi Ceylan, Ozgür Kemik.   

Abstract

The prevalance of osteoporosis or osteopenia in Turkish population with ulcerative colitis (UC) at the diagnosis time has not been evaluated so far. Therefore we aimed to determine the prevelance and risk factors of decreased bone mineral density (BMD) in UC patients at the diagnosis time in Turkey. We retrospectively evaluated dexa results, demographic and clinical characteristics, and some biochemical markers of bone turnover of the UC patients at the diagnosis time between June 2005 and February 2010 from the gastroenterology clinic records of the university hospital. The study population consisted of firstly diagnosed 63 UC patients (male: female = 27: 36; mean age 41.8 years). 38.1% at lumbar spine and 44.4% at femoral neck of the Turkish UC patients patients had low BMD at the diagnosis time. The occurrence of osteoporosis among Turkish UC patients at the diagnosis time were 8% at lumbar spine and 11% at femoral neck. 30.1% at lumbar spine and 33.3% at femoral neck of the patients had osteopenia at the diagnosis time. Pearson's coefficient of correlation showed significant correlations between low BMD and pancolitis (p<0.01), age, menopause, and symptom duration before the diagnosis (p<0.05).In conclusion, the prevelance of low bone density at the diagnosis time in Turkish UC patients is in accordance with Western and Eastern societies. Pancolitis, age, duration of symptoms, and menopause are predictive factors for low bone density in these patients.

Entities:  

Keywords:  Turkey; Ulcerative colitis; low bone density; osteopenia; osteoporosis; prevelance; risk factors

Year:  2011        PMID: 21686139      PMCID: PMC3113502     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Bone mineral density in patients with recently diagnosed inflammatory bowel disease.

Authors:  E J Schoon; B M Blok; B J Geerling; M G Russel; R W Stockbrügger; R J Brummer
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

2.  Relationship between bone mineral density and clinical features in patients with inflammatory bowel disease: a local study in Turkish population.

Authors:  S Poturoglu; F Balkan; Z E Karaali; D Ibrisim; S Yanmaz; M B Aktuglu; T Alioglu; M Kendir
Journal:  J Int Med Res       Date:  2010 Jan-Feb       Impact factor: 1.671

3.  Comparison of T- and Z-score in identifying risk factors of osteoporosis in inflammatory bowel disease patients.

Authors:  E Tsironi; D Hadjidakis; E Mallas; C Tzathas; D G Karamanolis; S D Ladas
Journal:  J Musculoskelet Neuronal Interact       Date:  2008 Jan-Mar       Impact factor: 2.041

4.  Femoral neck osteopenia in patients with inflammatory bowel disease.

Authors:  R D Pollak; F Karmeli; R Eliakim; Z Ackerman; K Tabb; D Rachmilewitz
Journal:  Am J Gastroenterol       Date:  1998-09       Impact factor: 10.864

5.  Anthropometric, lifestyle and menstrual factors influencing size-adjusted bone mineral content in a multiethnic population of premenopausal women.

Authors:  J W Davis; R Novotny; P D Ross; R D Wasnich
Journal:  J Nutr       Date:  1996-12       Impact factor: 4.798

Review 6.  Inflammatory bowel diseases, celiac disease, and bone.

Authors:  Maria Luisa Bianchi
Journal:  Arch Biochem Biophys       Date:  2010-06-30       Impact factor: 4.013

Review 7.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

8.  Bone density in young males with recently diagnosed inflammatory bowel disease.

Authors:  Grigorios T Sakellariou; John Moschos; Charalampos Berberidis; Aleksandros Mpoumponaris; Savvas Kadis; Epaminondas Molyvas; Georgios Kouklakis
Journal:  Joint Bone Spine       Date:  2006-04-19       Impact factor: 4.929

Review 9.  Review article: Osteoporosis and inflammatory bowel disease.

Authors:  C N Bernstein; W D Leslie
Journal:  Aliment Pharmacol Ther       Date:  2004-05-01       Impact factor: 8.171

10.  Low bone mineral density in patients with inflammatory bowel disease.

Authors:  F Pigot; C Roux; S Chaussade; D Hardelin; O Pelleter; T Du Puy Montbrun; V Listrat; M Dougados; D Couturier; B Amor
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

View more
  4 in total

1.  Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis.

Authors:  Bing Wang; Yang Song; Yan Chen; En-Sheng Wang; Dan Zheng; Fan Qu; Jian-Hong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis.

Authors:  Mirella Brasil Lopes; Andre Castro Lyra; Raquel Rocha; Fernanda Gomes Coqueiro; Carla Andrade Lima; Carolina Cunha de Oliveira; Genoile Oliveira Santana
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-07-05

3.  Normal range of BMD in proximal tibia as a different skeletal site at women.

Authors:  Mustafa Arif Aluclu; Fatih Bati; Ersoy Kekilli
Journal:  North Clin Istanb       Date:  2017-01-25

4.  [The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].

Authors:  Aida Ben Slama Trabelsi; Faouzi Abdellaoui; Mehdi Ksiaa; Ahlem Souguir; Hela Zeglaoui; Mohamed Ben Rejeb; Ahlem Brahem; Salem Ajmi; Ali Jmaa
Journal:  Pan Afr Med J       Date:  2013-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.